SEARCH

SEARCH BY CITATION

References

  • 1
    Malling H-J. Sublingual immunotherapy. Clin Exp Allergy 1996;26:1228 1231
  • 2
    Scadding GK & Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allergy 1986;16:483 491
  • 3
    Van Niekerk CH & De Wet JI. Efficacy of grass-maize pollen oral immunotherapy in patients with seasonal hay-fever: a double-blind study. Clin Allergy 1987;17:507 513
  • 4
    Casanovas M, Guerra F, Moreno C, Miguel R, Maranon F, Daza JC. Double-blind, placebo-controlled clinical trial of preseasonal treatment with allergenic extracts of Olea europaea pollen administered sublingually. J Investig Allergol Clin Immunol 1994;4:305 314
  • 5
    Clavel R, Bousquet J, André C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five grass pollen extract in rhinitis. Allergy 1998;53:493 498
  • 6
    Feliziani V, Lattuada G, Partmiani S, Dall' Aglio PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double-blind study. Allergol Immunopathol (Madr) 1995;23:224 230
  • 7
    Passalacqua G, Albano M, Fregonese L, et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998;351:629 632
  • 8
    Sabbah A, Hassoun S, Le Sellin J, André C, Sicard H. A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994;49:309 313
  • 9
    Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mites. A double-blind study. Allergol Immunopathol (Madr) 1990;8:277 284
  • 10
    Troise C, Voltolini S, Canessa A, Pecora S, Negrini AC. Sublingual immunotherapy in Parietaria pollen induced rhinitis: a double-blind study. J Investig Allergol Clin Immunol 1995;5:25 30
  • 11
    Vourdas D, Syrigou E, Potamianou P, et al. Double-blind placebo-controlled evaluation of sublingual immunotherapy with standardized olive tree pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive tree pollen sensitization. Allergy 1998;53:662 672
  • 12
    Nelson HS, Oppenheimer J, Vatsia GA, Buchmeier A. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract. J Allergy Clin Immunol 1993;92:229 236
  • 13
    Bousquet J, Hejjaoui A, Dhivert H, Clauzel AM, Michel FB. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. III. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol 1989;83:797 802
  • 14
    Bousquet J, Hejjaoui A, Dhivert H, Clauzel AM, Michel FB. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy. J Allergy Clin Immunol 1988;82:971 977
  • 15
    Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. CONSORT Statement. JAMA 1996;276:637 639
  • 16
    Van Wilsen EJG, Van Hoogstraten IMW, Brevé J, et al. Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair. Immunology 1994;83:128 132
  • 17
    Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Müller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J Immunol 1995;154:187 194
  • 18
    McHugh SM, Deighton J, Stewart AG, Lachmann PJ, Ewan PW. Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy. Clin Exp Allergy 1995;25:828 838